Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nasus Pharma Ltd. Logo
Nasus Pharma Ltd. Growth Score
66
CB Rank
39754
Heat Score
63
Nasus Pharma Ltd. is a health care company that develops powder-based Intranasal ( PBI ) specialized products to treat emergency patients.
Founded
obfuscation
PublicPost-IPO Equity Tel Aviv, Tel Aviv, Israel1-10 www.nasuspharma.com
Health Care
Medical
Pharmaceutical
Overview

Nasus Pharma Ltd.
Total Funding
obfuscation
Growth Score
66
Heat Score
63

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score66
-28 pts
in past quarter
Heat Score 63
-27 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Nasus Pharma Ltd.

CB Rank
39754
Nasus Pharma Ltd. is a health care company that develops powder-based Intranasal ( PBI ) specialized products to treat emergency patients.
Founded
obfuscation
PublicPost-IPO Equity Tel Aviv, Tel Aviv, Israel1-10 www.nasuspharma.com
Health Care
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Dalia Megiddo
    Dalia Megiddo: CEO
    Past Role: Alcobra Pharmaceuticals, Co-Founder
  • Photo of Eyal Rubin
    Eyal Rubin: Executive Vice President and Chief Financial Officer
    Past Role: BrainStorm Cell Therapeutics, EVP and Chief Financial Officer

Details

Also Known As Nasus Pharma Ltd.
Operating Status Active
Stock Symbol  NYSE:NSRX
Company Type For Profit
Contact Email info@nasuspharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Nasus Pharma Ltd. is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

FMXIN002 Intranasal Epinephrine
A powder-based intranasal epinephrine product designed for rapid treatment of severe allergic reactions and anaphylaxis.
FMXIN001 Intranasal Naloxone
A powder-based intranasal naloxone product intended for rapid reversal of opioid overdose in emergency situations.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Nasus Pharma Ltd. Logo
Post-IPO Equity - Nasus Pharma Ltd.
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News

News and Press

News•Jun 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

52
-95.11%
 in past month

Active Website Tech Count

11Nasus Pharma Ltd. is actively using 11 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m, PayPal, and  Vimeo.

Total IP

11The intellectual property of Nasus Pharma Ltd. includes 8 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Nasus Pharma Ltd. has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Nasus Pharma Ltd.'s headquarters? Nasus Pharma Ltd. is located in Tel Aviv, Tel Aviv, Israel.When was the last funding round for Nasus Pharma Ltd.? Nasus Pharma Ltd. closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Nasus Pharma Ltd.'s competitors? Alternatives and possible competitors to Nasus Pharma Ltd. may include Bryn Pharma, Nutriband, and  Belhaven Biopharma.How much funding has Nasus Pharma Ltd. raised to date? Nasus Pharma Ltd. has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|